Conference abstract · 6 Oct 2015
Conference abstractPublished 24 Aug 2015
Inducing cross-reactive responses
The University of Melbourne, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccines that exert their effects solely through the induction of highly specific neutralising antibodies can be effective but their benefit diminishes in a scenario of vaccine mismatch or if a new subtype of virus emerges. Cross-protective responses, such as those invoked and continuously boosted by natural infection, probably account for why most individuals experience clinical influenza on only a few occasions during their lifetime in response to antigenically drifted influenza strains. Cross-reactive immunity may also provide some protection against severe illness following infection with virus of a novel subtype. Current split virus vaccines induce very little if any cross-protective immunity against heterologous subtypes of virus and vaccine strategies that enable such responses would represent a substantial improvement. Proof of principle studies using two different strategies that potentially induce both highly specific neutralising antibody and heterosubtypic immunity in the form of cross-reactive cytotoxic T cells will be reported. The first of these is delivery of live virus by a non-productive route and the second is delivery of split virus vaccine in combination with an epitope-based TLR2-containing component. The “dose-sparing” effects of such vaccines will be discussed as well as the influence of routes of inoculation on the balance of antibody versus cytotoxic T cell immunity and the potency of the viral clearing response.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 16 Feb 2022
SARS-CoV-2 infection causes children to acquire long-lasting cross-reactive spike-specific immune responses
Opinion · 30 Jun 2025
Morphologic Clues to Organ Cross-Reactivity in Transplantation
Conference abstract · 1 Jun 2023
Serum levels of antibodies and cross-reactive antibodies against the spike protein variants of SARS-CoV-2 in the vaccinated people and non-vaccinated people who have recovered from natural infection
Perspective · 3 Mar 2023
Implication of Cross-Reactivity Associated with Genetics Modifications
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Lorena E. Brown”
